1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Gloo Holdings reported first quarter 2026 revenue of $41.5 million, up 238% from the prior-year period, and a net loss of $17.1 million, down from $27.0 million a year earlier. The company raised its fiscal 2026 revenue guidance to $195.0 million and guided second quarter revenue to $44.0 million and Adjusted EBITDA to negative $8.5 million. Shareholders get a clearer view of growth and a narrowing loss, though the company still reports a net loss and has not reached Adjusted EBITDA profitability.
Q1 2026 total revenue was $41.5 million, versus $12.3 million in the prior-year period, and above the $36.0 million consensus cited in the release.
Net loss narrowed to $17.1 million from $27.0 million; Adjusted EBITDA was negative $11.5 million, compared with negative $18.6 million in Q4 2025.
Fiscal 2026 revenue guidance raised to $195.0 million; Q2 2026 revenue expected at $44.0 million and Adjusted EBITDA at negative $8.5 million.
Gloo agreed to acquire the remaining 20% stake in Midwestern, which would remove a $12.1 million call option liability from its balance sheet.
Mama's Creations reported first-quarter fiscal 2027 results for the period ended April 30, 2026. Revenue rose 50% to $52.8 million and net income rose 66% to $2.1 million, or $0.05 per diluted share, but gross margin fell to 23.6% from 26.1%, which the company attributed to short-term start-up inefficiencies tied to new product launches. Cash and cash equivalents reached $24.4 million, and total debt was $5.1 million.
Revenue of $52.8 million versus $35.3 million a year earlier, up 49.7%
Net income of $2.1 million, or $0.05 per diluted share, versus $1.2 million, or $0.03, a year earlier
Gross margin of 23.6% versus 26.1%; management cited labor and raw material inefficiencies from new packaging and product start-ups
Cash of $24.4 million as of April 30, 2026, up from $20.0 million on January 31, 2026; total debt $5.1 million
Oil-Dri reported third-quarter fiscal 2026 results for the quarter ended April 30, 2026, with net sales of $126.3 million, up 9%, and net income of $14.5 million, up 25%. Its board also raised the quarterly dividend by about 10% and authorized repurchases of up to 500,000 more Common shares, though nine-month income from operations fell 5%.
Q3 net sales $126.3 million, up 9%; diluted EPS (Common) $1.00 versus $0.80 a year earlier.
Gross margin fell to 26.7% from 28.6%, partly offset by SG&A expenses down $2.5 million, or 13%.
Board declared quarterly dividend of $0.225 per Common share, payable August 21, 2026 to holders of record August 7, 2026.
Board authorized repurchase of up to 500,000 Common shares, in addition to 172,261 Common and 208,197 Class B shares available as of April 30, 2026.
U.S. Global Investors restated per-share results for the three and nine months ended March 31, 2026, after a spreadsheet omission understated weighted-average shares. The error changed only share counts and EPS; net income, revenue and operating income were not affected. Restated Q3 net income of $2.7 million compares with a net loss a year earlier, so shareholders see lower per-share figures but unchanged underlying profit.
Restated Q3 basic and diluted EPS is $0.21, down from $0.23 as reported; nine-month EPS is $0.26, down from $0.27.
Weighted-average shares for the quarter were understated by 702,484 shares; the company said net income, revenue and cash were not affected.
Q3 operating revenues were $2.8 million, up 31% from the same quarter of fiscal 2025 and up 10% from the prior quarter.
Q3 net income was $2.7 million, compared with a net loss of $382 thousand in the same quarter a year earlier.
Motorcar Parts of America reported fiscal 2026 fourth-quarter net sales up 9.9% to $212.3 million and net income of $9.7 million, or $0.42 per diluted share, versus a net loss of $722,000 a year earlier. For fiscal 2027 the company expects net sales of $780 million to $800 million, operating income of $86 million to $91 million, and EBITDA of $95 million to $100 million, which would be a meaningful increase in profit against fiscal 2026 operating income of $65.8 million.
Q4 fiscal 2026 net sales rose $19.2 million, or 9.9%, to $212.3 million, including $19.9 million of core revenue tied to inventory realignment at customer distribution centers.
Full-year fiscal 2026 net income was $12.4 million, or $0.62 per diluted share, versus a net loss of $19.5 million a year earlier; operating income was $65.8 million versus $39.9 million.
Fiscal 2027 guidance: net sales of $780 million to $800 million, operating income of $86 million to $91 million, and EBITDA of $95 million to $100 million.
The company repurchased 955,608 shares for $11.4 million in fiscal 2026 and had $22.1 million remaining under its current buyback authorization as of March 31, 2026.
Campbell's reported third-quarter fiscal 2026 net sales of $2.4 billion, down 4% on both a reported and organic basis, and adjusted EPS of $0.50, down 32% from $0.73. GAAP EPS rose to $0.41 from $0.22, largely because the prior-year quarter included a $150 million impairment charge. The company reaffirmed its full-year fiscal 2026 guidance for organic net sales, Adjusted EBIT and Adjusted EPS, so shareholders see weaker underlying profit this quarter but no change to the outlook.
Net sales were $2,366 million versus $2,475 million a year earlier, a 4% decline, with volume/mix down 5% and net price realization up 1%.
Adjusted gross profit margin fell 240 basis points to 27.7%, driven mainly by cost inflation, supply chain costs and tariffs.
Full-year fiscal 2026 guidance was reaffirmed: Adjusted EPS of $2.15 to $2.25, a 23% to 26% decline from fiscal 2025.
Cash flow from operations for the nine months was $839 million, compared with $872 million a year earlier; the company paid $380 million to shareholders year-to-date, mainly through dividends.
Seaport Therapeutics reported first-quarter 2026 results showing a net loss of $25.4 million, up from $13.1 million a year earlier, as research and development expenses roughly doubled to $21.4 million. The company had $212.6 million in cash, cash equivalents and investments at March 31, 2026, and said a May 2026 IPO that raised $260.0 million gross should fund operations into 2029, which matters to shareholders because the larger loss and new share issuance both bear on the company's cash runway and per-share results.
Net loss was $25.4 million for Q1 2026 versus $13.1 million for Q1 2025; net loss per share was $10.34 versus $5.65.
R&D expenses were $21.4 million versus $10.5 million, mainly from clinical development of GlyphAllo and GlyphAgo; G&A expenses were $6.1 million versus $5.7 million.
Cash, cash equivalents and investments were $212.6 million at March 31, 2026; the IPO closed in May 2026 with $260.0 million in gross proceeds.
Sharon Mates was appointed to the Board of Directors; Robert Nelson, Eric Elenko and Robert Lyne left the board in connection with the IPO.
Duluth Trading reported a fiscal first-quarter net loss of $10.0 million, down from $15.3 million a year earlier, while net sales fell 4.0% to $98.6 million. The company raised its fiscal 2026 Adjusted EBITDA guidance and affirmed its net sales guidance, so shareholders get a mixed picture of lower sales offset by better profitability and a higher profit outlook.
Net sales decreased 4.0% to $98.6 million from $102.7 million; direct-to-consumer sales fell 8.7% and retail store sales rose 3.3%.
Net loss was $10.0 million, or ($0.29) per share, versus a net loss of $15.3 million, or ($0.45) per share, a year earlier.
Adjusted EBITDA rose $6.4 million to $2.6 million; gross margin expanded 540 basis points to 57.4%.
Fiscal 2026 Adjusted EBITDA guidance was raised to $28 million to $32 million from $26 million to $30 million; net sales guidance of $540 million to $560 million was affirmed.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.